Vitreoretinal Surgery in Glaucoma

Abstract

Glaucoma is associated with the demise of retinal ganglion cells and their axons, primarily located in the retina. Vitreoretinal and glaucoma surgery overlap to a not inconsiderable extent in certain diseases. This overview article aims to present these diseases and highlight treatment strategies and the respective modes of action collectively. This article describes malignant glaucoma or aqueous misdirection syndrome, retinal surgery for choroidal detachment and expulsive choroidal hemorrhage, postoperative blebitis and endophthalmitis after glaucoma surgery, and vitrectomy after glaucoma surgery, along with the therapeutic paths for managing complications. The areas of glaucoma and vitreoretinal surgery are tightly linked. Colleagues from both subspecialties should be familiar with a certain overview of diseases concerning both subject areas.

Key words

glaucoma - retina - malignant glaucoma - aqueous misdirection syndrome

Publikationsverlauf

Eingereicht: 28. Februar 2022

Angenommen: 19. April 2022

Accepted Manuscript online:
20. April 2022

Artikel online veröffentlicht:
04. August 2022

• References/Literatur

• 1 Byrnes GA, Leen MM, Wong TP. et al. Vitrectomy for ciliary block (malignant) glaucoma. Ophthalmology 1995; 102: 1308-1311
• 2 Trope GE, Pavlin CJ, Bau A. et al. Malignant glaucoma. Clinical and ultrasound biomicroscopic features. Ophthalmology 1994; 101: 1030-1035
• 3 von Graefe A. Beiträge zur Pathologie und Therapie des Glaucoms. Archiv für Ophthalmologie 1869; 15: 108-252
• 4 Harbour JW, Rubsamen PE, Palmberg P. Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma. Arch Ophthalmol 1996; 114: 1073-1078
• 5 Little BC, Hitchings RA. Pseudophakic malignant glaucoma: Nd : YAG capsulotomy as a primary treatment. Eye (Lond) 1993; 7: 102-104
• 6 Tsai JC, Barton KA, Miller MH. et al. Surgical results in malignant glaucoma refractory to medical or laser therapy. Eye (Lond) 1997; 11: 677-681
• 7 Cashwell LF, Martin TJ. Malignant glaucoma after laser iridotomy. Ophthalmology 1992; 99: 651-658 discussion 658–659
• 8 Mastropasqua L, Ciancaglini M, Carpineto P. et al. Aqueous misdirection syndrome: a complication of neodymium: YAG posterior capsulotomy. J Cataract Refract Surg 1994; 20: 563-565
• 9 Hardten DR, Brown JD. Malignant glaucoma after Nd : YAG cyclophotocoagulation. Am J Ophthalmol 1991; 111: 245-247
• 10 Chandler PA, Simmons RJ, Grant WM. Malignant glaucoma. Medical and surgical treatment. Am J Ophthalmol 1968; 66: 495-502
• 11 Simmons RJ. Malignant glaucoma. Br J Ophthalmol 1972; 56: 263-272
• 12 Lau OC, Montfort JM, Sim BW. et al. Acute intraoperative rock-hard eye syndrome and its management. J Cataract Refract Surg 2014; 40: 799-804
• 13 Ruben S, Tsai J, Hitchings RA. Malignant glaucoma and its management. Br J Ophthalmol 1997; 81: 163-167
• 14 Greenfield DS, Tello C, Budenz DL. et al. Aqueous misdirection after glaucoma drainage device implantation. Ophthalmology 1999; 106: 1035-1040
• 15 Luntz MH, Rosenblatt M. Malignant glaucoma. Surv Ophthalmol 1987; 32: 73-93
• 16 Foreman-Larkin J, Netland PA, Salim S. Clinical Management of Malignant Glaucoma. J Ophthalmol 2015; 2015: 283707
• 17 Sharma A, Sii F, Shah P. et al. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes. Ophthalmology 2006; 113: 1968-1973
• 18 Dave P, Senthil S, Rao HL. et al. Treatment outcomes in malignant glaucoma. Ophthalmology 2013; 120: 984-990
• 19 Krix-Jachym K, Zarnowski T, Rekas M. Risk Factors of Malignant Glaucoma Occurrence after Glaucoma Surgery. J Ophthalmol 2017; 2017: 9616738
• 20 Sahoo NK, Balijepalli P, Singh SR. et al. Retina and glaucoma: surgical complications. Int J Retina Vitreous 2018; 4: 29
• 21 Gedde SJ, Herndon LW, Brandt JD. et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 2012; 153: 804-814.e1
• 22 Investigators A. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 2002; 134: 481-498
• 23 Jampel HD, Musch DC, Gillespie BW. et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 2005; 140: 16-22
• 24 Budenz DL, Barton K, Feuer WJ. et al. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology 2011; 118: 443-452
• 25 Reitsamer H, Sng C, Vera V. et al. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2019; 257: 983-996
• 26 Theilig T, Rehak M, Busch C. et al. Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep 2020; 10: 19337
• 27 Verma S, Azad SV, Takkar B. et al. Posterior segment complications following glaucoma surgeries. Indian J Ophthalmol 2020; 68: 988-993
• 28 Jeganathan VS, Ghosh S, Ruddle JB. et al. Risk factors for delayed suprachoroidal haemorrhage following glaucoma surgery. Br J Ophthalmol 2008; 92: 1393-1396
• 29 Learned D, Eliott D. Management of Delayed Suprachoroidal Hemorrhage after Glaucoma Surgery. Semin Ophthalmol 2018; 33: 59-63
• 30 Laube T, Brockmann C, Bornfeld N. Massive suprachoroidal hemorrhage: Surgical management and outcome. GMS Ophthalmol Cases 2015; 5: Doc10
• 31 Poulsen EJ, Allingham RR. Characteristics and risk factors of infections after glaucoma filtering surgery. J Glaucoma 2000; 9: 438-443
• 32 Wallin O, Al-ahramy AM, Lundstrom M. et al. Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. Acta Ophthalmol 2014; 92: 426-431
• 33 Ang GS, Varga Z, Shaarawy T. Postoperative infection in penetrating versus non-penetrating glaucoma surgery. Br J Ophthalmol 2010; 94: 1571-1576
• 34 Edmunds B, Thompson JR, Salmon JF. et al. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond) 2002; 16: 297-303
• 35 Stein JD, Ruiz jr. D, Belsky D. et al. Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. Ophthalmology 2008; 115: 1109-1116.e7
• 36 Busbee BG, Recchia FM, Kaiser R. et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology 2004; 111: 1495-1503 discussion 1503